Effect of acetogenin fraction of Annona muricata leaves on antioxidant status and some indices of benign prostatic hyperplasia in rats

References

• Kapoor A. Benign prostatic hyperplasia management in the primary care setting. Can J Urol. 2012;19(1):10–17.
   PubMedGoogle Scholar
• Kim JH, Park KM, Lee JA. Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials. Medicine (Baltimore). 2019;98(1):e14023. doi: 10.1097/MD.0000000000014023
   PubMed Web of Science ®Google Scholar
• Jadallah S, Li Y, Chu LW, et al. Prevalence of BPH and lower urinary tract symptoms in West Africans. Prost Cancer Prost Dis. 2012;15:170–176. doi: 10.1038/pcan.2011.43
   PubMed Web of Science ®Google Scholar
• Briganti A, Umberto C, Nazareno S, et al. Benign prostatic hyperplasia and its aetiologies. Eur Urol Suppl. 2009;8:865–871. doi: 10.1016/j.eursup.2009.11.002
   Web of Science ®Google Scholar
• Ejike CECC, Eze KC. Prevalence of symptoms of benign prostatic hyperplasia in Umudike and its relationship with measures of obesity. Asia Pac J Clin Nutr. 2015;7(1):1–8.
   Google Scholar
• Kaplan SA, Roehrborn CG, Rovner ES. Tolterodine and tamulsolin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006;296:2319–2328. doi: 10.1001/jama.296.19.2319
   PubMed Web of Science ®Google Scholar
• Nahata A, Dixit KV. Sphaeranthus indicus attenuates testosterone induced prostatic hypertrophy in albino rats. Phytother Res. 2011;25:1839–1848. doi: 10.1002/ptr.3497
   PubMed Web of Science ®Google Scholar
• Geavlete P, Multescu R, Geavlete B. Serenoa repens extract in the treatment of benign prostatic hyperplasia. Ther Adv Urol. 2011;3:193–198. doi: 10.1177/1756287211418725
   PubMedGoogle Scholar
• Heidenreich A, Bellmunt J, Bolla M, et al. Guidelines on prostate cancer. part 1: screening, diagnosis, treatment of clinically localized disease. Eur Urol. 2011;59:61–71. doi: 10.1016/j.eururo.2010.10.039
   PubMed Web of Science ®Google Scholar
• Kalu WO, Okafor PN, Ijeh II, et al. Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats. Biomed Pharmacother. 2016;83:1436–1443. doi: 10.1016/j.biopha.2016.08.064
   PubMed Web of Science ®Google Scholar
• Sharma M, Chadha R, Dhingra N. Phytotherapeutic agents for benign prostatic hyperplasia: an overview. Mini Rev Med Chem. 2017;17(14):1346–1363. doi: 10.2174/1389557516666160621103817
   PubMed Web of Science ®Google Scholar
• Fujita R, Liu J, Shimizu K, et al. Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol. 2005;102:107–112. doi: 10.1016/j.jep.2005.05.041
   PubMed Web of Science ®Google Scholar
• Xu Y, Ventura S. Extracts of bark from the traditional Chinese herb Phellodendron amurense inhibits contractility of the isolated rat prostate gland. J Ethnopharmacol. 2010;127:196–199. doi: 10.1016/j.jep.2009.09.047
   PubMed Web of Science ®Google Scholar
• Levy A, Sivanesan D, Murugan R, et al. Urtica dioica Induces cytotoxicity in human prostate carcinoma cells: involvement of oxidative stress. Mitochondrial depolarization and apoptosis. Trop J Pharm Res. 2014;13(5):711–717. doi: 10.4314/tjpr.v13i5.9
   Web of Science ®Google Scholar
• Coria-Tellez AV, Montalvo-Go E, Yahia EM, et al. Annona muricata: a comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity. Arab J Chem. 2018;11:662–691. doi: 10.1016/j.arabjc.2016.01.004
   Web of Science ®Google Scholar
• Adewole SO, Caxton-Martins EA. Morphological changes and hypoglycemic effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on pancreatic B-cells of streptozotocin-treated diabetic rats. Afr J Biomed Res. 2006;9:173–187.
   Google Scholar
• Moghadamtousi SZ, Fadaeinasab M, Nikzad S, et al. Annona muricata (Annonaceae): a review of its traditional uses, isolated acetogenins and biological activities. Int J Mol Sci. 2015;16(7):15625–15658. doi: 10.3390/ijms160715625
   PubMed Web of Science ®Google Scholar
• Asare GA, Afriyie D, Ngala RA, et al. Antiproliferative activity of aqueous leaf extract of Annona muricata L. on the prostate, BPH-1 cells, and some target genes. Integr Cancer Ther. 2015;14(1):65–74. doi: 10.1177/1534735414550198
   PubMed Web of Science ®Google Scholar
• Azimi H, Khakshur A-A, Aghdasi I, et al. A review of animal and human studies for management of benign prostatic hyperplasia with natural products: Perspective of new pharmacological agents. Inflamm Allergy Drug Targets. 2012;11:207–221. doi: 10.2174/187152812800392715
   PubMedGoogle Scholar
• Pagano E, Laudato M, Griffo M, et al. Phytotherapy of benign prostatic hyperplasia. A minireview. Phytother Res. 2013;28(7):949–955. doi: 10.1002/ptr.5084
   Web of Science ®Google Scholar
• Dreikorn K. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Curr Urol Rep. 2000;1:103–109. doi: 10.1007/s11934-000-0044-y
   PubMedGoogle Scholar
• Gecit I, Meral I, Aslan M, et al. Peripheral mononuclear leukocyte DNA damage, plasma prolidase activity, and oxidative status in patients with benign prostatic hyperplasia. Redox Rep. 2015;20(4):163–169. doi: 10.1179/1351000214Y.0000000121
   PubMed Web of Science ®Google Scholar
• Minciullo PL, Inferrera A, Navarra M, et al. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol Int. 2015;94:249–254. doi: 10.1159/000366210
   PubMed Web of Science ®Google Scholar
• Roduan MRM, Hamid RA, Kqueen CY, et al. Cytotoxicity, antitumor-promoting and antioxidant activities of Annona muricata in vitro. J Herb Med. 2019;15(2):100219. doi: 10.1016/j.hermed.2018.04.004
   Google Scholar
• Baskar R, Rajeswari V, Kumar TS. In vitro antioxidant studies in leaves of Annona species. IJEB. 2007;45:480–485.
   PubMed Web of Science ®Google Scholar
• Mulia K, Winarcahyo SW, Krisanti E, et al. Practical isolation of Bullatacin from Annona muricata leaves extract using an open column chromatography Technique. Adv Mater Res. 2013;789:545–550. doi: 10.4028/www.scientific.net/AMR.789.545
   Google Scholar
• Pimenta LPS, Garcia GM, Gonçalves SGV, et al. In vivo antimalarial efficacy of acetogenins, alkaloids and flavonoids enriched fractions from Annona crassiflora Mart. Nat Prod Res. 2014;28(16):1254–1259. doi: 10.1080/14786419.2014.900496
   PubMed Web of Science ®Google Scholar
• Yang C, Gundala SR, Mukkavilli R, et al. Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer. Carcinogenesis. 2015;36(6):656–665. doi: 10.1093/carcin/bgv046
   PubMed Web of Science ®Google Scholar
• Mulia K, Krisanti E, Maulana T, et al. Selective polarity-guided extraction and purification of acetogenins in Annona muricata L. leaves. Int J Technol. 2015;7:1221–1227. doi: 10.14716/ijtech.v6i7.1983
   Google Scholar
• Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol. 1983;53:275–289. doi: 10.1007/BF01234480
   PubMed Web of Science ®Google Scholar
• Shin IS, Lee MY, Ha HK, et al. Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone induced benign prostatic hyperplasia in rats. BMC Compl Alternative Med. 2012;12:48. doi: 10.1186/1472-6882-12-48
   PubMed Web of Science ®Google Scholar
• Tietz NW. Clinical Guide to laboratory tests. Philadelphia: W.B. Saunders, Co.; 1995. p. 216–580.
   Google Scholar
• Wallin B, Rosengren B, Shertzer HG, et al. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances (TBARS) formation in a single microtitre plate: Its use for evaluation of antioxidants. Anal Biochem. 1993;208:10–15. doi: 10.1006/abio.1993.1002
   PubMed Web of Science ®Google Scholar
• Arthur JR, Boyne R. Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci. 1985;36:1569–1575. doi: 10.1016/0024-3205(85)90381-9
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169.
   PubMed Web of Science ®Google Scholar
• Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–394. doi: 10.1016/0003-2697(72)90132-7
   PubMed Web of Science ®Google Scholar
• Exner R, Wessner B, Manhart N, et al. Therapeutic potential of glutathione. Wien Klin Wochenschr. 2000;112:610–616.
   PubMed Web of Science ®Google Scholar
• Padma P, Chansouria J, Khosa R. Effect of alcohol extract of Annona muricata on cold immobilization stress induced tissue lipid peroxidation. Phytother Res. 1997;11:326–327. doi: 10.1002/(SICI)1099-1573(199706)11:4<326::AID-PTR94>3.0.CO;2-B
   Web of Science ®Google Scholar
• Gajalakshmi S, Vijayalakshmi S, Rajeswari DV. Phytochemical pharmacological properties of Annona muricata: a review. Int J Pharm Pharm Sci. 2012;4(2):0975–1491.
   Google Scholar
• Choi H, Jung Y, Park J, et al. Cinnamomi cortex (Cinnamomum verum) suppresses testosterone-induced benign prostatic hyperplasia by regulating 5α-reductase. Sci Rep. 2016;6:31906. doi: 10.1038/srep31906
   PubMed Web of Science ®Google Scholar
• Sing B, Ram SN, Pandey VB, et al. Studies on antiinflammatory activity of taraxasterol acetate from Echinops echinatus in rats and mice. Phytother Res. 1991;5:103–106. doi: 10.1002/ptr.2650050303
   Web of Science ®Google Scholar
• Shin I, Lee M, Jung D, et al. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia. Food Chem Toxicol. 2012;50:884–888. doi: 10.1016/j.fct.2012.01.007
   PubMed Web of Science ®Google Scholar
• Ejike CECC, Ezeanyika LUS. Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds. Urol Int. 2011;87:218–224. doi: 10.1159/000327018
   PubMed Web of Science ®Google Scholar
• Khandrika L, Kumar B, Koul S, et al. Oxidative stress in prostate cancer. Cancer Lett. 2009;282:125–136. doi: 10.1016/j.canlet.2008.12.011
   PubMed Web of Science ®Google Scholar
• Djavan B, Milani S, Fong YK. Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia. Expert Opin Pharmacol. 2005;6(2):311–317. doi: 10.1517/14656566.6.2.311
   PubMed Web of Science ®Google Scholar